O

OrbiMed Portfolio holdings

AUM $3.98B
1-Year Est. Return 13.05%
This Quarter Est. Return
1 Year Est. Return
+13.05%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$9.47B
AUM Growth
-$1.57B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
145
New
Increased
Reduced
Closed

Top Buys

1
+$95.1M
2
+$76.2M
3
+$74M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$72.1M
5
LLY icon
Eli Lilly
LLY
+$66.8M

Top Sells

1
+$205M
2
+$143M
3
+$75.8M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$56.3M
5
BMY icon
Bristol-Myers Squibb
BMY
+$49.2M

Sector Composition

1 Healthcare 90.2%
2 Financials 0.22%
3 Technology 0.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
51
$44M 0.46%
3,469,900
52
$42.3M 0.44%
5,397,698
53
$40.2M 0.42%
2,627,394
-1,465,068
54
$40.2M 0.42%
72,993
+294
55
$39.2M 0.41%
+1,401,600
56
$38M 0.4%
1,974,700
-497,500
57
$34.4M 0.36%
+7,989,916
58
$31.5M 0.33%
10,689,000
59
$29.1M 0.31%
+335,100
60
$27.6M 0.29%
1,850,094
61
$27.1M 0.28%
6,000,400
+232,000
62
$23M 0.24%
501,000
+338,000
63
$22.7M 0.24%
212,000
+26,000
64
$19.6M 0.21%
3,723,528
-692,772
65
$17.1M 0.18%
838,100
-463,600
66
$17M 0.18%
2,667,500
67
$14.9M 0.16%
90,778
-15,367
68
$14.9M 0.16%
1,107,022
69
$14.7M 0.15%
393,180
-65,082
70
$14.1M 0.15%
1,746,100
-703,800
71
$13.8M 0.15%
90,745
72
$13.8M 0.14%
190,600
-113,500
73
$13.6M 0.14%
166,000
+20,000
74
$13.6M 0.14%
114,000
-23,229
75
$13.2M 0.14%
1,140,325
1 2
3
4 5